Seilern Europa CHF U I |
Performance History | 30/04/2024 |
Growth of 1,000 (EUR) |
Fund | - | 27.9 | -24.0 | 14.6 | 5.3 | |
+/-Cat | - | 3.3 | -3.5 | -1.5 | 0.2 | |
+/-Idx | - | - | - | -1.6 | -2.1 | |
Category: Europe Large-Cap Growth Equity | ||||||
Benchmarks: Morningstar DM Europe Grt T... |
Key Stats | ||
NAV 13/05/2024 | CHF 134.27 | |
Day Change | 0.01% | |
Morningstar Category™ | Europe Large-Cap Growth Equity | |
ISIN | IE00BMPRPV58 | |
Fund Size (Mil) 13/05/2024 | EUR 71.75 | |
Share Class Size (Mil) 13/05/2024 | CHF 0.11 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 23/02/2024 | 0.94% |
Investment Objective: Seilern Europa CHF U I |
The investment objective of the fund is to seek capital appreciation through investment in equity or equity related securities (i. e. equity warrants and convertible bonds) of the highest quality companies listed on the stock exchanges of the European OECD member countries. The fund may purchase securities denominated in any of the major convertible currencies of the European member countries of the OECD. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Fernando Leon 18/05/2018 | ||
Tassilo Seilern 14/07/2014 | ||
Inception Date 16/04/2020 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe GR EUR | Morningstar DM Europe Grt TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Seilern Europa CHF U I | 31/01/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 8.40 |
Lonza Group Ltd | Healthcare | 7.99 |
Dassault Systemes SE | Technology | 7.94 |
SAP SE | Technology | 7.88 |
Rightmove PLC | Communication Services | 5.92 |
Increase Decrease New since last portfolio | ||
Seilern Europa CHF U I |